These findings collectively indicate that selective deletion of PLXND1 in CD11c+ DCs significantly enhances inflammation during asthma, as evidenced by increased recruitment of inflammatory cells and overall histopathological changes in lung tissue. The gene discussed is PLXND1; the disease is asthma.